Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL21P132 (ribosomal protein L21 pseudogene 132) is a pseudogene associated with the ribosomal protein L21 gene family. Unlike the functional RPL21 gene, which encodes a component of the 60S ribosomal subunit involved in protein synthesis, RPL21P132 does not produce a functional protein and lacks biological or therapeutic relevance. Pseudogenes like RPL21P132 are DNA sequences resembling known genes but typically lack coding potential due to mutations or lack of necessary regulatory elements. RPL21P132 is not a functional gene, and there is no evidence it acts as an enzyme, receptor, transporter, or other therapeutic target. It is annotated as a non-functional pseudogene in key resources. It should not be confused with the functional RPL21 gene (ribosomal protein L21), which is a structural component of ribosomes. If information on the active ribosomal protein is sought, refer to the RPL21 entry, not RPL21P132.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 132 (RPL21P132).